These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 17099339)

  • 21. Hormone replacement therapy--is there a place for its use in neurology?
    Vuković V; Lovrencić-Huzjan A; Solter VV; Dordević V; Demarin V
    Coll Antropol; 2003 Jun; 27(1):413-24. PubMed ID: 12974172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The new conundrum: do estrogens have any cardiovascular benefits?
    Clarkson TB
    Int J Fertil Womens Med; 2002; 47(2):61-8. PubMed ID: 11991432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estrogens are indicated for the prevention of coronary artery disease: a debate for estrogen.
    Leiter LA
    Can J Cardiol; 2000 Aug; 16 Suppl E():13E-16E. PubMed ID: 10906619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hormone therapy and cardiovascular disease.
    Chen FP
    Taiwan J Obstet Gynecol; 2006 Dec; 45(4):287-93. PubMed ID: 17175484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tissue ACE inhibitors for secondary prevention of cardiovascular disease in patients with preserved left ventricular function: a pooled meta-analysis of randomized placebo-controlled trials.
    Saha SA; Molnar J; Arora RR
    J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):192-204. PubMed ID: 17875946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Where are we with postmenopausal hormone therapy in 2005?
    Lam PM; Chung TK; Haines C
    Gynecol Endocrinol; 2005 Nov; 21(5):248-56. PubMed ID: 16373243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postmenopausal hormone therapy in clinical perspective.
    Hodis HN; Mack WJ
    Menopause; 2007; 14(5):944-57. PubMed ID: 17353803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hormone replacement therapy and the cardiovascular system lessons learned and unanswered questions.
    Ouyang P; Michos ED; Karas RH
    J Am Coll Cardiol; 2006 May; 47(9):1741-53. PubMed ID: 16682298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of postmenopausal hormone therapy on cardiovascular risk.
    Rossouw JE
    J Hypertens Suppl; 2002 May; 20(2):S62-5. PubMed ID: 12183856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prevention of coronary heart disease by early postmenopausal hormone therapy: new supporting data].
    Gaspard U
    J Gynecol Obstet Biol Reprod (Paris); 2008 Jun; 37(4):340-5. PubMed ID: 18249506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-dose statin therapy for secondary prevention of stroke: stroke prevention by aggressive reduction in cholesterol levels study review.
    Schwertz DW; Badellino KO
    J Cardiovasc Nurs; 2008; 23(1):8-13. PubMed ID: 18158500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system?
    Rosano GM; Vitale C; Fini M
    Ann N Y Acad Sci; 2006 Dec; 1092():341-8. PubMed ID: 17308159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hormonal replacement therapy and selective estrogen receptor modulators in prevention of cardiovascular disease].
    Kozakiewicz K; Wycisk A
    Wiad Lek; 2006; 59(5-6):377-82. PubMed ID: 17017486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hormone replacement therapy and cardiovascular disease revisited.
    Stevenson JC
    Menopause Int; 2009 Jun; 15(2):55-7. PubMed ID: 19465669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials.
    Saha SA; Molnar J; Arora RR
    Diabetes Obes Metab; 2008 Jan; 10(1):41-52. PubMed ID: 18095949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of cardiovascular events in early menopause: a possible role for hormone replacement therapy.
    Antonicelli R; Olivieri F; Morichi V; Urbani E; Mais V
    Int J Cardiol; 2008 Nov; 130(2):140-6. PubMed ID: 18617278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
    Windler E; Zyriax BC; Eidenmüller B; Boeing H
    Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Invited commentary: hormone therapy and risk of coronary heart disease why renew the focus on the early years of menopause?
    Manson JE; Bassuk SS
    Am J Epidemiol; 2007 Sep; 166(5):511-7. PubMed ID: 17646204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.
    Motovska Z; Kala P
    Clin Ther; 2008; 30 Pt 2():2191-202. PubMed ID: 19281914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen replacement does not prevent recurrent stroke or death in postmenopausal women after an ischemic stroke.
    Basile JN
    J Clin Hypertens (Greenwich); 2002; 4(1):48-9. PubMed ID: 11821638
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.